These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16682605)

  • 1. Phakic status affects vitreous penetration of topical moxifloxacin.
    Fuller JJ; McGwin G
    Arch Ophthalmol; 2006 May; 124(5):749; author reply 749. PubMed ID: 16682605
    [No Abstract]   [Full Text] [Related]  

  • 2. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.
    Hariprasad SM; Blinder KJ; Shah GK; Apte RS; Rosenblatt B; Holekamp NM; Thomas MA; Mieler WF; Chi J; Prince RA
    Arch Ophthalmol; 2005 Jan; 123(1):39-44. PubMed ID: 15642810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
    Kampougeris G; Antoniadou A
    Eye (Lond); 2007 Sep; 21(9):1242-3; author reply 1243. PubMed ID: 17618246
    [No Abstract]   [Full Text] [Related]  

  • 4. Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.
    Chang Lin JE; Welty D
    Surv Ophthalmol; 2006; 51(5):530; author reply 530-1. PubMed ID: 16950254
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitreous penetration of topical moxifloxacin and gatifloxacin in humans.
    Costello P; Bakri SJ; Beer PM; Singh RJ; Falk NS; Peters GB; Melendez JA
    Retina; 2006 Feb; 26(2):191-5. PubMed ID: 16467677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
    McCulley JP; Caudle D; Aronowicz JD; Shine WE
    Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.
    Hariprasad SM; Shah GK; Chi J; Prince RA
    J Cataract Refract Surg; 2005 Nov; 31(11):2142-6. PubMed ID: 16412929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cataract surgery on ocular levels of topical moxifloxacin.
    Mather R; Stewart JM; Prabriputaloong T; Wong J; McLeod SD
    Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
    Hariprasad SM; Shah GK; Mieler WF; Feiner L; Blinder KJ; Holekamp NM; Gao H; Prince RA
    Arch Ophthalmol; 2006 Feb; 124(2):178-82. PubMed ID: 16476886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.
    Chung JL; Lim EH; Song SW; Kim BY; Lee JH; Mah FS; Seo KY
    Cornea; 2013 Jul; 32(7):1046-51. PubMed ID: 23615274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.
    Kim DH; Stark WJ; O'Brien TP; Dick JD
    Ophthalmology; 2005 Nov; 112(11):1992-6. PubMed ID: 16183125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of aqueous humor concentrations of fluoroquinolones.
    Scassellati Sforzolini B; Sheets JW; Morris TW
    J Cataract Refract Surg; 2011 Jan; 37(1):217-8. PubMed ID: 21183123
    [No Abstract]   [Full Text] [Related]  

  • 13. Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
    Vedantham V; Lalitha P; Velpandian T; Ghose S; Mahalakshmi R; Ramasamy K
    Eye (Lond); 2006 Nov; 20(11):1273-8. PubMed ID: 16200061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.
    Robertson SM; Curtis MA; Schlech BA; Rusinko A; Owen GR; Dembinska O; Liao J; Dahlin DC
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S32-45. PubMed ID: 16257309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
    Yağci R; Oflu Y; Dinçel A; Kaya E; Yağci S; Bayar B; Duman S; Bozkurt A
    Eye (Lond); 2007 Jul; 21(7):990-4. PubMed ID: 16732216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreous and aqueous penetration of orally and topically administered moxifloxacin.
    Fukuda M; Shibata N; Osada H; Yamashiro Y; Sasaki H
    Ophthalmic Res; 2011; 46(3):113-7. PubMed ID: 21325873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application.
    Donnenfeld ED; Comstock TL; Proksch JW
    J Cataract Refract Surg; 2011 Jun; 37(6):1082-9. PubMed ID: 21596251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of intravitreal moxifloxacin.
    Iyer MN; He F; Wensel TG; Mieler WF; Benz MS; Holz ER
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):317-9. PubMed ID: 16384979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery.
    Kim DH; Stark WJ; O'Brien TP
    Curr Med Res Opin; 2005 Jan; 21(1):93-4. PubMed ID: 15881479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
    Holland EJ; Lane SS; Kim T; Raizman M; Dunn S
    Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.